Zist Darou Danesh Company
Zist Darou Danesh Company is a private specialty pharmaceutical company headquartered in Tehran, Iran. It researches, develops, manufactures and markets recombinant and chemical medicines for complex diseases, spanning oncology, neurology, endocrinology, multiple sclerosis, ALS and orphan-disease care. The company is relevant to specialty-drug buyers, distributors and partners evaluating Iranian pharmaceutical development and export-registration capabilities.
Operations & footprint
Products and services
Zist Darou Danesh Company researches, develops, manufactures, and markets specialty medicines for complex diseases, including recombinant and chemical pharmaceutical products in oncology, neurology, orphan diseases, dermatology-rheumatology, iron deficiency, endocrinology, diabetes, MS, ALS, cancer, aesthetic drugs, and other specialized therapeutic areas. Its activity includes pharmaceutical R&;D, patient support, clinical education, export registration, and GMP-based specialty-drug production.
Operations and assets
The company combines pharmaceutical R&;D, GMP-based specialty-drug production and commercialization. Its activities include patient-support and clinical-education programmes alongside export-registration work.
Geographic footprint
Tehran, Tehran Province, Iran.
Commercial and investment relevance
Zist Darou Danesh is relevant for investors assessing Iran's specialty-drug market, biologics and recombinant medicine capability, oncology and neurology demand, orphan-drug access, export potential, and high-value pharmaceutical localization. It can support analysis of how domestic companies move into advanced therapies under sanctions, pricing regulation, and technology constraints. Due diligence should verify ownership, relationship with PMA or related holdings, GMP and EAEU GMP certification status, product registrations, export destinations, clinical evidence, pharmacovigilance systems, API and biologic input sourcing, manufacturing site status, and exposure to intellectual-property or regulatory risk. Zist Darou Danesh is relevant to partners seeking specialty pharmaceutical products and development capabilities in oncology, neurology, endocrinology and rare-disease care. Its export-registration activity also makes it a potential counterpart for market-entry and distribution discussions.
Constraints, risk & compliance
Key risks and constraints
Commercial performance depends on maintaining appropriate product registrations and GMP-based manufacturing for specialty medicines. Product-specific clinical evidence, pharmacovigilance arrangements, manufacturing capacity and API or biologic-input sourcing require diligence.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Zist Darou Danesh Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Zist Darou Danesh Company do?
Zist Darou Danesh researches, develops, manufactures and markets recombinant and chemical specialty medicines for complex diseases.
Where is Zist Darou Danesh Company based?
The company is headquartered in Tehran, Tehran Province, Iran.
Which therapeutic areas does Zist Darou Danesh serve?
Its stated focus includes oncology, neurology, orphan diseases, dermatology-rheumatology, iron deficiency, endocrinology, diabetes, multiple sclerosis and ALS.
Does Zist Darou Danesh have export-related activity?
The company includes export registration among its activities.